Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study

References

• Francisco CP, Cua IH, Aguila EJ, et al. Moving forward: gradual return of gastroenterology practice during the COVID-19 pandemic. Dig Dis (Basel, Switz). 2020;39:140–149.
   Google Scholar
• Goodsall TM, Han S, Bryant RV. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2020;3:1550–1555.
   Google Scholar
• Rubin DT, Feuerstein JD, Wang AY, et al. AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary. Gastroenterology. 2020;159(1):350–357.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Ardizzone S. Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? J Crohns Colitis. 2020;14(9):1334–1336.
   PubMed Web of Science ®Google Scholar
• Neurath MF. COVID-19 and immunomodulation in IBD. Gut. 2020;69(7):1335–1342.
   PubMed Web of Science ®Google Scholar
• Sethi A, Swaminath A, Latorre M, New York Society for Gastrointestinal Endoscopy, et al. Donning a new approach to the practice of gastroenterology: perspectives from the COVID-19 pandemic epicenter. Clin Gastroenterol Hepatol. 2020;18(8):1673–1681.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Abreu MT, Rai V, International Organization for the Study of Inflammatory Bowel Disease, et al. Management of patients with Crohn’s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting. Gastroenterology. 2020;159(1):6–13.e6.
   PubMed Web of Science ®Google Scholar
• Magro F, Rahier JF, Abreu C, et al. Inflammatory bowel disease management during the COVID-19 outbreak: the ten Do's and Don'ts from the ECCO-COVID Taskforce. J Crohns Colitis. 2020;14(14 Suppl 3):S798–S806.
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481–1491.
   PubMed Web of Science ®Google Scholar
• Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144(1):36–49.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Hitchon CA, Walld R, et al. The impact of psychiatric comorbidity on health care utilization in inflammatory bowel disease: a population-based study. Inflamm Bowel Dis. 2020;27(9):1462–1474.
   Web of Science ®Google Scholar
• Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(11):2303–2308.
   PubMed Web of Science ®Google Scholar
• Horesh D, Brown AD. Traumatic stress in the age of COVID-19: a call to close critical gaps and adapt to new realities. Psychol Trauma Theory Res Pract Policy. 2020;12(4):331–335.
   PubMed Web of Science ®Google Scholar
• Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychol. 2020;33(2):e100213.
   Web of Science ®Google Scholar
• D'Amico F, Rahier J-F, Leone S, et al. Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey. Lancet Gastroenterol Hepatol. 2020;5(7):631–632.
   PubMed Web of Science ®Google Scholar
• Trindade IA, Ferreira NB. COVID-19 pandemic’s effects on disease and psychological outcomes of people with inflammatory bowel disease in Portugal: a preliminary research. Inflamm Bowel Dis. 2021;27(8):1224–1229.
   PubMed Web of Science ®Google Scholar
• Mosli M, Alourfi M, Alamoudi A, et al. A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia. Saudi J Gastroenterol. 2020;26(5):263–271.
   PubMed Web of Science ®Google Scholar
• Ballou S, Gray S, Palsson OS. Validation of the pandemic emotional impact scale. Brain Behav Immun Health. 2020;9:100161.
   PubMedGoogle Scholar
• Palsson O, Ballou S, Gray S. The U.S. National Pandemic Emotional Impact Report. Accessed September 15, 2020. http://pandemicimpactreport.com/.
   Google Scholar
• Smith BW, Dalen J, Wiggins K, et al. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194–200.
   PubMed Web of Science ®Google Scholar
• Goodwin R, Gaines SO, Myers L, et al. Initial psychological responses to swine flu. Int J Behav Med. 2011;18(2):88–92.
   PubMed Web of Science ®Google Scholar
• Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.
   PubMed Web of Science ®Google Scholar
• Connor J, Madhavan S, Mokashi M, et al. Health risks and outcomes that disproportionately affect women during the Covid-19 pandemic: a review. Soc Sci Med. 2020;266:113364.
   PubMed Web of Science ®Google Scholar
• Chan W, Chen A, Tiao D, et al. Medication adherence in inflammatory bowel disease. Intest Res. 2017;15(4):434–445.
   PubMed Web of Science ®Google Scholar
• Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003;114(1):39–43.
   PubMed Web of Science ®Google Scholar
• Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53(4):1020–1024.
   PubMed Web of Science ®Google Scholar
• Herman ML, Kane SV. Treatment nonadherence in inflammatory bowel disease: identification, scope, and management strategies. Inflamm Bowel Dis. 2015;21(12):2979–2984.
   PubMed Web of Science ®Google Scholar
• Brenner EJ, Ungaro RC, Gearry RB, et al. But not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159(2):481–491.
   PubMed Web of Science ®Google Scholar
• Kunzendorf S, Jantschek G, Straubinger K, et al. The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(1):33–41.
   PubMed Web of Science ®Google Scholar
• Sehgal P, Ungaro RC, Foltz C, et al. High levels of psychological resilience associated with less disease activity, better quality of life, and fewer surgeries in inflammatory bowel disease. Inflamm Bowel Dis. 2020; 27(6): 791–796.
   Web of Science ®Google Scholar